Loading clinical trials...
Loading clinical trials...
Whole blood samples will be collected from high-risk pregnant women to validate the clinical performance of the SEQureDx Trisomy 21 Test.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Sequenom, Inc.
NCT04726241 · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and more
NCT07296861 · Down Syndrome, Child Obesity
NCT03233646 · Alzheimer's Disease, Mild Cognitive Impairment, and more
NCT07366593 · Down Syndrome
NCT07213063 · Down Syndrome (DS), Supplementation
University of South Alabama
Mobile, Alabama
Visions Clinical Research Tuscon
Tucson, Arizona
Obstetrix Medical Group of California
Campbell, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions